| Literature DB >> 28275391 |
Paola Arnaboldi1, Serena Oliveri2, Valeria Vadilonga1, Luigi Santoro3, Angelo Maggioni4, Gabriella Pravettoni2.
Abstract
OBJECTIVE: To investigate patients' satisfaction and perceived utility for psychological consultations delivered by clinical psychologists in a sample of gynaecological cancer patients hospitalised for surgery.Entities:
Keywords: patient satisfaction; cancer patients’ distress; gynaecological cancer surgery setting; interprofessional practice; psychological intervention
Year: 2017 PMID: 28275391 PMCID: PMC5336389 DOI: 10.3332/ecancer.2017.722
Source DB: PubMed Journal: Ecancermedicalscience ISSN: 1754-6605
Figure 1.Development of the integrative psychological intervention.
Patients’ characteristics.
| 51 | |
| Age (years) | Mean (sd) |
| 54.1 (13.4) | |
| <50 | 16 (31.4) |
| 50–59 | 17 (33.3) |
| ≥60 | 18 (35.3) |
| Diagnosis | |
| Cancer ovary | 24 (48.0) |
| Cancer uterus | 15 (30.0) |
| Cancer vulva | 5 (10.0) |
| Other diagnosis | 6 (12.0) |
| Stage of disease | |
| First diagnosis | 37 (72.6) |
| Recurrence | 14 (27.4) |
| Number of psy sessions | |
| 1 | 26 (51.0) |
| 2 | 17 (33.2) |
| 3 | 3 (5.9) |
| 4 | 1 (2.0) |
| 5 | 1 (2.0) |
| 6 | 1 (2.0) |
| 8 | 2 (3.9) |
| Type of intervention^ | |
| Assessment | 32 (64.0) |
| Empowerment | 18 (36.0) |
| Other reason from cancer (6 months follow-up) | |
| No | 35 (68.6) |
| Yes | 16 (31.4) |
benign disease.
Variation of distress: comparison between subgroups.
| Distress pre-surgery | Distress post-surgery (6-month follow-up) | |||||||
|---|---|---|---|---|---|---|---|---|
| Mean (SD) | Test value | Mean (SD) | Test value | |||||
| ALL | 51 | 7.69 (2.0) | 44 | 6.95 (2.6) | ||||
| Age (years) | 0.07 | 0.80 | ||||||
| < 50 | 16 | 8.1 (1.9) | 5.221 | 12 | 7.0 (2.7) | 0.429 | ||
| 50;59 | 18 | 8.2 (1.6) | 17 | 7.2 (2.2) | ||||
| ≥ 60 | 17 | 6.7 (2.3) | 15 | 6.5 (2.9) | ||||
| Diagnosis | 0.81 | 0.95 | ||||||
| Cancer ovary | 24 | 7.6 (2.1) | 0.942 | 20 | 7.0 (2.1) | 0.327 | ||
| Cancer uterus | 15 | 7.3 (2.4) | 13 | 7.0 (2.4) | ||||
| 5 | 8.2 (1.6) | 5 | 8.2 (1.6) | |||||
| Other diagnosis | 6 | 8.5 (1.0) | 5 | 8.5 (1.0) | ||||
| Stage of disease | 0.46 | |||||||
| First diagnosis | 37 | 8.0 (1.9) | 259.5 | 31 | 6.74 | 669.5” | ||
| Recurrence | 14 | 6.6 (2.1) | 13 | 7.46 | ||||
| Number of interviews | 0.81 | 0.45 | ||||||
| 1 | 26 | 7.5 (2.0) | 0.95 | 22 | 6.5 (2.8) | 2.62 | ||
| 2 | 17 | 7.7 (2.3) | 15 | 7.2 (2.6) | ||||
| 3 | 3 | 8.6 (1.1) | 2 | 9.0 (1.4) | ||||
| ≥4 | 5 | 7.8 (1.9) | 5 | 6.8 (1.4) | ||||
| Type of intervention | 0.42 | 0.09 | ||||||
| Assessment | 32 | 7.8 (2.0) | 420.0” | 26 | 7.5 (2.3) | 336.0” | ||
| Empowerment | 18 | 7.3 (2.1) | 18 | 6.1 (2.8) | ||||
| Other reason from Cancer (6 months follow-up) | 0.87 | |||||||
| No | 35 | 7.7 (1.9) | 408.5” | 28 | 6.1 (2.7) | 521.0” | ||
| Yes | 16 | 7.5 (2.3) | 16 | 8.3 (1.7) | ||||
Kruskal–Wallis test
Wilcoxon’s test
p < 0.05
p < <0.01
Satisfaction and perceived utility of the consultation: comparison between subgroups at 6-month follow-up.
| Hospitalisation | Personal issues | Returning home | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mean | Test value (Kw or W) | Mean | Test value (Kw or W) | Mean | Test value (Kw or W) | |||||||
| Age (years) | 3.07 | 2.36 | 0.43 | 0.87 | 4.63 | 3.63 | ||||||
| < 50 | 7 | 9.4 (1.1) | 7 | 8.8 (1.2) | 6 | 8.6 (1.5) | ||||||
| 50–59 | 14 | 8.5 (1.2) | 8 | 9.1 (1.1) | 14 | 8.0 (1.1) | ||||||
| ≥ 60 | 10 | 9.0 (1.2) | 8 | 8.5 (1.4) | 10 | 8.8 (1.8) | ||||||
| Diagnosis | 2.73 | 4.74 | 3.28 | 3.40 | 6.03 | 0.34 | ||||||
| Cancer ovary | 12 | 8.5 (1.2) | 9 | 9.1 (1.1) | 14 | 8.0 (1.7) | ||||||
| Cancer uterus | 9 | 9.0 (1.3) | 8 | 8.5 (1.4) | 9 | 8.3 (1.3) | ||||||
| Cancer vulva | 4 | 10.0 (0.0) | 2 | 10 (0.0) | 4 | 9.2 (0.9) | ||||||
| Other diagnosis | 5 | 8.8 (1.3) | 3 | 8.6 (0.5) | 2 | 8.5 (0.7) | ||||||
| Stage of disease | 3.63 | 106.5 | 40.5” | 2.54 | 345.5” | |||||||
| First diagnosis | 23 | 9.0 (1.1) | 19 | 8.9 (1.2) | 23 | 8.3 (1.5) | ||||||
| Recurrence | 8 | 8.5 (1.4) | 4 | 8.5 (1.2) | 7 | 8.7 (1.2) | ||||||
| Number of interviews | 4.14 | 2.41 | 3.23 | 0.18 | 1.85 | 4.09 | ||||||
| 1 | 13 | 8.6 (1.2) | 10 | 8.7 (1.4) | 14 | 7.8 (1.6) | ||||||
| 2 | 9 | 9.0 (1.3) | 7 | 9.0 (1.1) | 9 | 8.5 (1.1) | ||||||
| 3 | 2 | 10.0 (0.0) | 1 | 9.0 (0.0) | 2 | 8.5 (2.1) | ||||||
| ≥ 4 | 5 | 8.8 (1.3) | 3 | 8.6 (1.5) | 4 | 9.5 (1.0) | ||||||
| Type of intervention | 5.37 | 287.5 | 1.93 | 95.5” | 0.61 | 188.0” | ||||||
| Assessment | 18 | 8.8 (1.2) | 14 | 9.0 (1.2) | 17 | 8.5 (1.3) | ||||||
| Empowerment | 13 | 8.9 (1.1) | 9 | 8.5 (1.2) | 13 | 8.1 (1.7) | ||||||
| Other reason from Cancer (6 months follow-up) | 0.29 | 159.5” | 7.13 | 90.5” | 4.76 | 325.5” | ||||||
| No | 21 | 8.9 (1.7) | 15 | 8.9 (1.1) | 22 | 8.3 (1.2) | ||||||
| Yes | 10 | 8.9 (1.3) | 8 | 8.6 (1.5) | 8 | 8.5 (2.1) | ||||||
Kruskal–Wallis test
Wilcoxon’s test
p < 0.05
p < 0.01